F. Gary Toback
Corporate Officer/Principal chez The University of Chicago
Profil
F.
Gary Toback is a Professor at The University of Chicago since 1985.
He was a Founding Scientist & Consultant at NephRx Corp.
He completed his undergraduate degree at The Trustees of Columbia University in The City of New York and his doctorate at Boston University and New York University.
Postes actifs de F. Gary Toback
| Sociétés | Poste | Début |
|---|---|---|
| The University of Chicago | Corporate Officer/Principal | 01/01/1985 |
Anciens postes connus de F. Gary Toback
| Sociétés | Poste | Fin |
|---|---|---|
NephRx Corp.
 NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Directeur Technique/Scientifique/R&D | - |
Formation de F. Gary Toback
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| New York University | Doctorate Degree |
| Boston University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
NephRx Corp.
NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Health Technology |
